Propafenone efficacy in treatment of atrial fibrillation paroxysms: a placebo-controlled study
In a placebo-controlled study, propafenone efficacy and safety for pharmaceutical cardioversion in atrial fibrillation (AF) paroxysms were studied. The study included 50 patients aged 28-69 years (mean age 53,9+9,7), with AF paroxysms lasting for less than 48 hours. Participants were randomized to p...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Russo |
| Gepubliceerd in: |
«FIRMA «SILICEA» LLC
2005-12-01
|
| Reeks: | Российский кардиологический журнал |
| Onderwerpen: | |
| Online toegang: | https://russjcardiol.elpub.ru/jour/article/view/2343 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|